找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Ciprofloxacin i.v.; Defining Its Role in Christopher Garrard (Intensive Care Director) Conference proceedings 1994 Springer-Verlag Berlin H

[复制链接]
楼主: GERM
发表于 2025-3-26 21:09:39 | 显示全部楼层
发表于 2025-3-27 03:46:05 | 显示全部楼层
Conference proceedings 1994ty and therapeutic use of the antibiotic substance Ciprofloxacin. Of special interest for clinicians will be the clinical outcome in patients with nosocomial pneumonia and other infections of the lower respiratory tract.
发表于 2025-3-27 06:43:52 | 显示全部楼层
Efficacy and Safety of Ciprofloxacin in Various Intravenous Dosages,g b.i.d. We wished to obtain clinical experience, particularly in severe nosocomial infections caused by resistant organisms, using not only the permitted i.v. standard dose but also higher i.v. doses.
发表于 2025-3-27 11:48:20 | 显示全部楼层
,Conversion from Intravenous to Oral Ciprofloxacin: Observing the “Like-to-Like” Phenomenon,ular attention has been placed on oral fluoroquinolones, for these agents exhibit favorable pharmacokinetic and microbiologic characteristics, have shown efficacy in the treatment of a variety of infectious diseases [1, 11], and can reduce the cost of antibiotic therapy [12–17].
发表于 2025-3-27 16:36:43 | 显示全部楼层
Intravenous Ciprofloxacin for the Treatment of Lower Respiratory Tract Infections: Preliminary Resua few days of clinical improvement. Studies so far performed have demonstrated that in various serious infections oral ciprofloxacin can shorten the course of parenteral antibiotics and thus minimize the period of hospitalization and reduce costs [2–6].
发表于 2025-3-27 21:36:18 | 显示全部楼层
Regional Integration in Trade Theoryg b.i.d. We wished to obtain clinical experience, particularly in severe nosocomial infections caused by resistant organisms, using not only the permitted i.v. standard dose but also higher i.v. doses.
发表于 2025-3-27 22:08:16 | 显示全部楼层
Joseph Aversa,Tony Hernandez,Sean Dohertyular attention has been placed on oral fluoroquinolones, for these agents exhibit favorable pharmacokinetic and microbiologic characteristics, have shown efficacy in the treatment of a variety of infectious diseases [1, 11], and can reduce the cost of antibiotic therapy [12–17].
发表于 2025-3-28 04:25:08 | 显示全部楼层
Jamal Jokar Arsanjani,Ruben López Vázqueza few days of clinical improvement. Studies so far performed have demonstrated that in various serious infections oral ciprofloxacin can shorten the course of parenteral antibiotics and thus minimize the period of hospitalization and reduce costs [2–6].
发表于 2025-3-28 06:17:30 | 显示全部楼层
发表于 2025-3-28 13:44:02 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-25 05:16
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表